Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Apixaban 5 mg vs Eliquis 5 mg in healthy Thai volunteers (fasting, crossover)
TCTR20230203002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20230203002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230203002.